论文部分内容阅读
对１９９２年１０月至１９９５年１２月中晚期肝癌采用双介入治疗方法。对照组（单纯ＨＡＥ＋ＨＡＩ）１年生存率为３３％，综合组（单纯ＨＡＥ＋ＨＡＩ超声介入下瘤体内药物注射）１年生存率为５６．７％。ＡＦＰ下降幅度单纯组为６０％，综合组为７６．６％。为提高中晚期肝癌治疗疗效，又辟新途径。
Double-interventional treatment was used to treat advanced liver cancer from October 1992 to December 1995. The one-year survival rate in the control group (simple HAE+HAI) was 33%, and the one-year survival rate in the comprehensive group (intratumoral injection of HAE+HAI alone) was 56.7%. The AFP decline rate was 60% in the simple group and 76.6% in the comprehensive group. In order to improve the efficacy of treatment of advanced liver cancer, but also open up new ways.